Meloxicam Mcc (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the synthesis of prostaglandins that drive inflammation, pain, and fever. By sparing COX‑1, it aims to provide anti‑inflammatory and analgesic effects while limiting gastric side effects compared with non‑selective NSAIDs.

The appropriate dose of meloxicam is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, renal and hepatic function, and other individual factors. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for meloxicam in pregnancy and lactation are limited. It is generally advised to avoid use during the first trimester and throughout pregnancy unless the potential benefit outweighs the risk. Breastfeeding mothers should consult a healthcare professional, as the drug may be excreted in milk.

To order Meloxicam Mcc, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Meloxicam is more COX‑2 selective than many traditional NSAIDs, which may lower the risk of gastrointestinal irritation while still offering effective anti‑inflammatory and analgesic action. However, it still carries cardiovascular and renal risks similar to other NSAIDs, so patient risk factors must be evaluated before use.

Meloxicam Mcc should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and potency throughout its shelf life.

Meloxicam Mcc is supplied as a rectal formulation intended for insertion into the rectum, typically as a suppository. Administration should follow the prescribing information, ensuring proper positioning and hygiene to maximize absorption and therapeutic effect.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as myocardial infarction or stroke, severe liver injury, and acute renal impairment. Patients should be monitored for signs of abdominal pain, sudden weight gain, swelling, jaundice, or changes in urine output, and seek medical attention promptly if they occur.

Meloxicam should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, uncontrolled hypertension, and those with significant renal or hepatic impairment unless specifically directed by a physician.